New drug class effective in treating certain types of ovarian cancers
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.
Rucaparib is in a relatively new class of drugs - Poly(ADP-ribose) polymerase or PARP inhibitors - which have been approved for therapy in ovarian cancers. This study provides insights into both how the cancers resist treatments, and which patients may respond favorably to the drug, said lead author Dr. Elizabeth Swisher, a UW Medicine gynecologic oncologist and a professor of obstetrics and gynecology at the University of Washington School of Medicine. She also co-directs the Breast and Ovarian Cancer Research Program at the Seattle Cancer Care Alliance.
New class of drug gives hope to some ovarian cancer patients newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.
Partnering up with Abiraterone Acetate – Potentials for a Harmonious Relationship
Published 03 May 2021
Abiraterone acetate has demonstrated benefit across the metastatic prostate cancer spectrum when combined or layered on conventional androgen deprivation therapy. Whether it be metastatic castration-sensitive (mCSPC) or metastatic castration-resistant prostate cancer (mCRPC) in either the pre-or the post-docetaxel setting, the overall survival benefit is certain.
1-4 Attempts to advance to the next level with additional agents added to abiraterone acetate, in the first-line mCRPC setting, have been met with mixed results. At this time, other than the continuing foundation of androgen deprivation therapy, there is no therapeutic agent regulatory approved for combination with abiraterone acetate.
Deconstructing monogamy: Why Wired868’s ‘Outside Woman’ is ahead of the game like the Greek Hetairae
Sunday 25 April 2021
Thursday 22 April 2021
Thursday 7 January 2021
Wednesday 4 November 2020
Tuesday 20 April 2021
Deconstructing monogamy: Why Wired868’s ‘Outside Woman’ is ahead of the game like the Greek Hetairae
First, the disclaimer. Disabuse yourself of the assumption I am against marriage and monogamy. You could not be further from the truth.
I’m not only a veteran in the practice, I shared some supportive insight on how to do monogamy successfully; with eyes wide open, realistic expectations and cost/benefit ratio rooted in the reality of your health and happiness here and now, not some fantasy afterlife for which there is no empirical evidence of existence.